Canada markets close in 3 hours 41 minutes

Arch Therapeutics, Inc. (ARTH)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.2135+0.0335 (+2.88%)
As of 11:57AM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-09-30
2022-09-30
2021-09-30
2020-09-30
Total Revenue
115.33
75.724
15.652
11.565
0
Cost of Revenue
84.134
78.163
51.489
26.282
0
Gross Profit
31.196
-2.439
-35.837
-14.717
0
Operating Expenses
Research Development
715.007
670.88
1,153
1,353
1,611
Selling General and Administrative
4,580
4,371
4,520
5,009
3,741
Total Operating Expenses
5,295
5,042
5,673
6,362
5,352
Operating Income or Loss
-5,263
-5,044
-5,709
-6,377
-5,352
Interest Expense
3,759
3,097
567.048
150.531
18.534
Total Other Income/Expenses Net
-
1,158
1,000
287.173
679.271
Income Before Tax
-7,864
-6,983
-5,276
-6,240
-4,691
Income from Continuing Operations
-7,864
-6,983
-5,276
-6,240
-4,691
Net Income
-7,864
-6,983
-5,276
-6,240
-4,691
Net Income available to common shareholders
-7,864
-6,983
-5,276
-6,240
-4,691
Basic EPS
-4.72
-2.27
-4.40
-6.00
-4.00
Diluted EPS
-4.72
-2.27
-4.40
-6.00
-4.00
Basic Average Shares
1,260
3,074
1,200
1,100
940.258
Diluted Average Shares
1,260
3,074
1,200
1,100
940.258